IndustryPayments

SHIKHA WADHWANI

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology CHICAGO, IL NPI 1467763441

Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology IL CALLIDITAS THERAPEUTICS US INC. All categories

General Payments — all program years on this page

$156,530.42

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 185
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $41,447.19 across 46 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $24,607.506
Travel and Lodging $14,756.3712
Food and Beverage $2,071.2524
Education $12.074

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
CALLIDITAS THERAPEUTICS US INC. $13,340.837
Retrophin, Inc. $12,061.9228
Boehringer Ingelheim International GmbH $11,048.716
Otsuka Pharmaceutical Development & Commercialization, Inc. $4,927.502
GlaxoSmithKline, LLC. $38.031
NOVARTIS PHARMACEUTICALS CORPORATION $30.202

By program year

Program yearAmountRecords
2018 $141.862
2019 $2,838.347
2020 $1,500.001
2021 $5,407.235
2022 $36,351.0828
2023 $68,844.7296
2024 $41,447.1946

Records — PY2024 (46)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087439596 Novartis Pharmaceuticals Corporation $14.46 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087439598 Novartis Pharmaceuticals Corporation $15.74 05/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116692549 GlaxoSmithKline, LLC. $38.03 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118022496 Boehringer Ingelheim International GmbH $12.76 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118022498 Boehringer Ingelheim International GmbH $32.72 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118022500 Boehringer Ingelheim International GmbH $81.81 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118022502 Boehringer Ingelheim International GmbH $650.12 07/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118022504 Boehringer Ingelheim International GmbH $10,258.54 08/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118022506 Boehringer Ingelheim International GmbH $12.76 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118840321 Otsuka Pharmaceutical Development & Commercialization, Inc. $2,190.00 07/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118840323 Otsuka Pharmaceutical Development & Commercialization, Inc. $2,737.50 11/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141509549 CALLIDITAS THERAPEUTICS US INC. $6,240.00 02/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141509551 CALLIDITAS THERAPEUTICS US INC. $476.93 02/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141515819 CALLIDITAS THERAPEUTICS US INC. $21.98 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141520575 CALLIDITAS THERAPEUTICS US INC. $117.06 08/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141524198 CALLIDITAS THERAPEUTICS US INC. $2,400.00 10/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141527438 CALLIDITAS THERAPEUTICS US INC. $3,840.00 11/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141527440 CALLIDITAS THERAPEUTICS US INC. $244.86 11/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149920081 Travere Therapeutics, Inc. $2.38 05/09/2024 Education Undisputed 01/23/2026 View at CMS
1149920084 Travere Therapeutics, Inc. $3.23 05/09/2024 Education Undisputed 01/23/2026 View at CMS
1149920088 Travere Therapeutics, Inc. $3.23 05/09/2024 Education Undisputed 01/23/2026 View at CMS
1149920092 Travere Therapeutics, Inc. $3.23 05/09/2024 Education Undisputed 01/23/2026 View at CMS
1149920096 Travere Therapeutics, Inc. $35.00 10/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149920100 Travere Therapeutics, Inc. $54.59 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920104 Travere Therapeutics, Inc. $60.08 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920109 Travere Therapeutics, Inc. $87.87 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920113 Travere Therapeutics, Inc. $89.15 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920117 Travere Therapeutics, Inc. $104.74 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920121 Travere Therapeutics, Inc. $119.83 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920125 Travere Therapeutics, Inc. $124.69 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920129 Travere Therapeutics, Inc. $126.54 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920133 Travere Therapeutics, Inc. $150.00 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920137 Travere Therapeutics, Inc. $288.72 10/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149920141 Travere Therapeutics, Inc. $296.48 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149920145 Travere Therapeutics, Inc. $336.92 10/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149920149 Travere Therapeutics, Inc. $350.39 11/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149920153 Travere Therapeutics, Inc. $405.16 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920157 Travere Therapeutics, Inc. $476.52 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149920161 Travere Therapeutics, Inc. $73.43 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149920165 Travere Therapeutics, Inc. $7,200.00 10/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1149961288 Travere Therapeutics, Inc. $35.39 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149961290 Travere Therapeutics, Inc. $72.34 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149961294 Travere Therapeutics, Inc. $81.58 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149961298 Travere Therapeutics, Inc. $138.54 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149961302 Travere Therapeutics, Inc. $607.94 12/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149961305 Travere Therapeutics, Inc. $733.95 11/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.